Key result
Treadmill testing reveals reversible myocardial ischemia in ~31% of asymptomatic patients with T2DM.
Why the study?
Type 2 diabetes mellitus is a risk factor for coronary artery disease, but the prevalence of CAD in asymptomatic T2DM patients and its correlation with invasive testing needed assessment.
What is the prevalence of silent coronary artery disease identified by treadmill testing in asymptomatic patients with type 2 diabetes mellitus?
Cross-Sectional (n=90)
What is the prevalence of silent coronary artery disease identified by treadmill testing in asymptomatic patients with type 2 diabetes mellitus?
There is a high prevalence (31.1%) of silent ischemia in asymptomatic T2DM patients, with a significant proportion of those tested invasively requiring revascularization.
Silent CAD prevalence hits 31% on TMT in asymptomatic T2DM; leaves open whether routine screening improves outcomes.
Introduction: Type 2 diabetes mellitus (T2DM) is the risk factor for coronary artery disease (CAD). Material and Methods: In this study, we assessed the prevalence of CAD in asymptomatic T2DM patients and its correlation with invasive testing in treadmill testing (TMT)-positive cases. A total of 90 patients with asymptomatic T2DM were recruited and subjected to TMT TMT-positive patients were subjected to coronary angiography (CAG). Results: At baseline, the mean duration of T2DM (years) was 4.87 ± 4.04 with mean levels of HbA1c (%) of 7.96 ± 1.02. TMT was positive in 28 patients (31.1%) for reversible myocardial ischaemia (RMI), and among them, 16 patients consented to CAG, of which 14 required coronary angioplasty and the remaining two (7.1%) had to undergo coronary artery bypass grafting (CABG). The remaining 12 TMT positives (42.9%) were managed medically. Conclusion: To conclude, there is a high prevalence of silent CAD in T2DM. They need regular screening to detect the same and prevent the morbidity and mortality associated with overt CAD. Hence, it is important to screen people with type 2 diabetes, to prevent the morbidity and mortality associated with overt CAD.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2023) conducted a cross-sectional in Asymptomatic type 2 diabetes mellitus (n=90). Asymptomatic type 2 diabetes mellitus was evaluated on Reversible myocardial ischaemia on treadmill testing. In asymptomatic patients with type 2 diabetes mellitus, treadmill testing revealed reversible myocardial ischemia in 31.1% of cases, highlighting a high prevalence of silent coronary artery disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: